My Companies
Notification
Account
Minipress XL acquisition ₹1250Cr revenue ₹228Cr, ophthalm Accentrix Pagenax in-licensing ₹10Cr, 900+ fieldforce, Voveran Macalvit Methergin in-house, Q2-Q4 FY27 transition costs, CFO appointed
Novartis India Signs ₹10 Crore Exclusive Agreement For Retina Portfolio
Novartis India Approves ₹1,250 Crore Minipress Acquisition From Pfizer
Novartis India Terminates Dr Reddy’s Exclusive Distribution Agreement